Trial Profile
An open label pilot study of Zoledronate (Aclasta 5mg iv) in the treatment of Ankylosing Spondylitis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Nov 2014
Price :
$35
*
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Ankylosing spondylitis
- Focus Therapeutic Use
- 15 Sep 2014 Results presented at the 36th Annual Meeting of the American Society for Bone and Mineral Research.
- 09 Jun 2011 New trial record